Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 20 to 85

Using antibiotics to prevent infections in patients with gastric varices undergoing treatment

Official title: Antibiotic Prophylaxis in Patients Undergoing Endoscopic Injection of Cyanoacrylate for Primary and Secondary Prevention of Gastric Variceal Bleeding

Run by Taipei Veterans General Hospital, Taiwan · NCT04140578 · Data updated 2026-11-12

This study is testing if giving antibiotics to patients with liver disease and gastric varices during treatment can help prevent infections and reduce the chances of bleeding again.

More Sepsis trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages20 Years to 85 Years
SexAll
Enrollment150 (estimated)
SponsorTaipei Veterans General Hospital, Taiwan
Government
Locations1 site (Taipei)
StatusRecruiting
StartedJanuary 28, 2017
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedOctober 28, 2019
Trial IDNCT04140578 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 20 to 85 with liver cirrhosis or hepatoma who have gastric varices but no esophageal varices.

Probably not a fit

Patients with terminal illnesses affecting major organ systems, recent antibiotic use, or suspected infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine the necessity of antibiotic prophylaxis in patients with chronic liver disease and gastric varices who are treated with endoscopic variceal obturation (GVO). The study will involve a randomized approach to assess the effectiveness of Ertapenem in preventing septic infections and reducing the rebleeding rate associated with gastric variceal bleeding. Given the high rebleeding rates and potential complications from current treatment methods, this trial seeks to clarify the role of antibiotics in improving patient outcomes. Participants will be closely monitored for any adverse effects and treatment efficacy.

Why it matters

Potential benefit: If successful, this study could significantly reduce the risk of infections and rebleeding in patients with gastric varices, improving their overall treatment outcomes.

How similar studies have gone: Other studies have explored antibiotic prophylaxis in similar contexts, but this specific approach using Ertapenem in gastric varices is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with live cirrhosis and/or hepatoma
2. Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV

Exclusion Criteria:

1. Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD
2. Patients recieve antibiotics recently.
3. Patients suspected infection.

Where it's running

  • Veteran General Hospital-Taipei
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Ming-Chih Hou — Taipei Veterans General Hospital, Taiwan
  • Study coordinator: Ming-Chih Hou, MD
  • Email: mchou@vghtpe.gov.tw
  • Phone: 886-2-28712111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.